Monthly Archives: February 2014

Brain Tumors and Cancer Stem Cells – Highlights from Brain Works 2013 – Video

Posted: February 18, 2014 at 2:42 pm


Brain Tumors and Cancer Stem Cells - Highlights from Brain Works 2013
Excerpt from Brain Works 2013, a free community event from Washington University and Barnes-Jewish Hospital. Register for our next brain innovation event at:...

By: Barnes-Jewish Hospital

See original here:
Brain Tumors and Cancer Stem Cells - Highlights from Brain Works 2013 - Video

Posted in Stem Cell Videos | Comments Off on Brain Tumors and Cancer Stem Cells – Highlights from Brain Works 2013 – Video

Parkinson’s Disease- Dr. Ashworth Discusses How Stem Cells Helped his Parkinson’s Disease – Video

Posted: February 18, 2014 at 2:42 pm


Parkinson #39;s Disease- Dr. Ashworth Discusses How Stem Cells Helped his Parkinson #39;s Disease
Dr. Ashworth came to Dr. Steenblock to help with his Parkinson #39;s Disease. He got amazing results after having a stem cell treatment. To learn more about how ...

By: David Steenblock

Excerpt from:
Parkinson's Disease- Dr. Ashworth Discusses How Stem Cells Helped his Parkinson's Disease - Video

Posted in Stem Cell Videos | Comments Off on Parkinson’s Disease- Dr. Ashworth Discusses How Stem Cells Helped his Parkinson’s Disease – Video

Don Margolis Stem Cells 101 – Introduction – Video

Posted: February 18, 2014 at 2:42 pm


Don Margolis Stem Cells 101 - Introduction
Did you know that inside your body right now is a medicine that can effectively treat over 100 so-called "untreatable" diseases? Don Margolis of the Repair S...

By: Bill Hammerton

See original here:
Don Margolis Stem Cells 101 - Introduction - Video

Posted in Stem Cell Treatments | Comments Off on Don Margolis Stem Cells 101 – Introduction – Video

Scientists 'rejuventate' stem cells in elderly mice to repair muscles

Posted: February 18, 2014 at 11:45 am

PALO ALTO, Calif., Feb. 17 (UPI) -- In an experiment with mice, U.S. scientists say they've enabled muscle recovery in elderly mice by rejuvenating stem cells within their muscle tissue.

Normal aging is accompanied by a diminished ability to regain strength and mobility after muscle injury because over time stem cells within muscle tissues dedicated to repairing damage become less able to generate new muscle fibers and struggle to self-renew, researchers at Stanford University reported Sunday.

"In the past, it's been thought that muscle stem cells themselves don't change with age, and that any loss of function is primarily due to external factors in the cells' environment," Helen Blau of the university's school of medicine said.."However, when we isolated stem cells from older mice, we found that they exhibit profound changes with age. In fact, two-thirds of the cells are dysfunctional when compared to those from younger mice, and the defect persists even when transplanted into young muscles."

However, Blau and her colleagues say they've identified for the first time a process by which the older muscle stem cell populations can be rejuvenated to function like younger cells.

"Our findings identify a defect inherent to old muscle stem cells," she said. "Most exciting is that we also discovered a way to overcome the defect. As a result, we have a new therapeutic target that could one day be used to help elderly human patients repair muscle damage."

The researchers used drugs to block elevated biological activity within the stem cells that causes them to degenerate into non-stem, muscle progenitor cells.

When transplanted back into the animal, the treated, rejuvenated stem cells migrate to their natural niches and provide a long-lasting stem cell reserve to contribute to repeated demands for muscle repair, they researchers said.

"In mice, we can take cells from an old animal, treat them for seven days -- during which time their numbers expand dramatically, as much as 60-fold -- and then return them to injured muscles in old animals to facilitate their repair," Blau said.

View original post here:
Scientists 'rejuventate' stem cells in elderly mice to repair muscles

Posted in Stem Cells | Comments Off on Scientists 'rejuventate' stem cells in elderly mice to repair muscles

Older Muscle Stem Cells Rejuvenated to Function Like Younger Cells, May Help Elderly Repair Muscle

Posted: February 18, 2014 at 11:45 am

E-mail this page to a friend!

Health & Medicine for Senior Citizens

Older Muscle Stem Cells Rejuvenated to Function Like Younger Cells, May Help Elderly Repair Muscle

Stanford researchers pinpoint why normal aging is accompanied by a diminished ability to regain strength and mobility after muscle injury

By Krista Conger

Feb. 17, 2014 - Researchers at the Stanford University School of Medicine have pinpointed why normal aging is accompanied by a diminished ability to regain strength and mobility after muscle injury: Over time, stem cells within muscle tissues dedicated to repairing damage become less able to generate new muscle fibers and struggle to self-renew.

In the past, its been thought that muscle stem cells themselves dont change with age, and that any loss of function is primarily due to external factors in the cells environment, said Helen Blau, PhD, the Donald and Delia B. Baxter Foundation Professor.

However, when we isolated stem cells from older mice, we found that they exhibit profound changes with age. In fact, two-thirds of the cells are dysfunctional when compared to those from younger mice, and the defect persists even when transplanted into young muscles.

Blau and her colleagues also identified for the first time a process by which the older muscle stem cell populations can be rejuvenated to function like younger cells. Our findings identify a defect inherent to old muscle stem cells, she said. Most exciting is that we also discovered a way to overcome the defect. As a result, we have a new therapeutic target that could one day be used to help elderly human patients repair muscle damage.

Blau, a professor of microbiology and immunology and director of Stanfords Baxter Laboratory for Stem Cell Biology, is the senior author of a paper describing the research, published online Feb. 16 in Nature Medicine. Postdoctoral scholar Benjamin Cosgrove, PhD, and former postdoctoral scholar Penney Gilbert, PhD, now an assistant professor at the University of Toronto, are the lead authors.

Read the original post:
Older Muscle Stem Cells Rejuvenated to Function Like Younger Cells, May Help Elderly Repair Muscle

Posted in Stem Cells | Comments Off on Older Muscle Stem Cells Rejuvenated to Function Like Younger Cells, May Help Elderly Repair Muscle

Acid test for STAP cells

Posted: February 18, 2014 at 11:45 am

Claims by a Japanese research team that it made pluripotent stem cells simply by exposing normal mouse cells to acid baths and other stresses are now being investigated for "alleged irregulaties," according to an online article Monday in the journal Nature.

Mouse cells exposed to an acidic environment turned into embryonic-like "STAP" cells. These were used to generate an entire fetus. / Haruko Obokata

The study itself was published in Nature on Jan. 29. It gained widespread acclaim, but a number of scientists expressed doubts about the STAP cells on second thought. UC Davis stem cell researcher Paul Knoepfler gave his reasons for skepticism in a Feb. 6 blog post. Among his reasons: Evolution should have selected against such a mechanism, because cellular stress is a common part of life, and pluripotent stem cells produce tumors.

At the very least, researchers who have tried to replicate the findings aren't having an easy time doing so, according to an unscientific poll Knoepfler is running. The trend has turned from mostly positive to evenly split, Knoepfler reported in the second week of polling.

"Its also notable that respondents from Japan have shifted the most in opinion. In week 1 they were disproportionately positive, while in week 2 they became disproportionately negative," Knoepfler wrote.

Jeanne Loring, the TSRI stem cell researcher who I interviewed when the discovery was first announced, told me earlier this month that her lab, "along with everyone else in the universe," was trying to replicate the results.

"What I told my lab was, go ahead and do it; don't tell me about it until you have results, and don't let it interfere with the rest of your work," Loring said.

Life scientists from other fields weighed in on Twitter with their skepticism.

"Acid bath makes stem cells??? If it looks too good to be true, it probably is," wrote tart-tongued evolutionary biologist Dan Graur, who notably applied acid to claims by the ENCODE project (in its press release) that 80 percent of the human genome is functional.

Read more:
Acid test for STAP cells

Posted in Stem Cells | Comments Off on Acid test for STAP cells

Rejuvenated Stem Cells Help Aging Muscles Heal

Posted: February 18, 2014 at 11:45 am

Researchers at the Stanford University School of Medicine have pinpointed why normal aging is accompanied by a diminished ability to regain strength and mobility after muscle injury: Over time, stem cells within muscle tissues dedicated to repairing damage become less able to generate new muscle fibers and struggle to self-renew.

A release from the university quotes Helen Blau PhD, the Donald and Delia B. Baxter Foundation Professor, as saying, "In the past, it's been thought that muscle stem cells themselves don't change with age, and that any loss of function is primarily due to external factors in the cells' environment. However, when we isolated stem cells from older mice, we found that they exhibit profound changes with age. In fact, two-thirds of the cells are dysfunctional when compared to those from younger mice, and the defect persists even when transplanted into young muscles."

The release explains that Blau and her colleagues also identified for the first time a process by which the older muscle stem cell populations can be rejuvenated to function like younger cells. "Our findings identify a defect inherent to old muscle stem cells," she said. "Most exciting is that we also discovered a way to overcome the defect. As a result, we have a new therapeutic target that could one day be used to help elderly human patients repair muscle damage."

Blau, a professor of microbiology and immunology and director of Stanford's Baxter Laboratory for Stem Cell Biology, is the senior author of a paper describing the research, which was published online Feberuary 16th 2014 in Nature Medicine. Postdoctoral scholar Benjamin Cosgrove, PhD, and former postdoctoral scholar Penney Gilbert, PhD, now an assistant professor at the University of Toronto, are the lead authors. The researchers found that many muscle stem cells isolated from mice that were two years old, equivalent to about 80 years of human life, exhibited elevated levels of activity in a biological cascade called the p38 MAP kinase pathway. This pathway impedes the proliferation of the stem cells and encourages them to instead become non-stem, muscle progenitor cells. As a result, although many of the old stem cells divide in a dish, the resulting colonies are very small and do not contain many stem cells. Using a drug to block this p38 MAP kinase pathway in old stem cells (while also growing them on a specialized matrix called hydrogel) allowed them to divide rapidly in the laboratory and make a large number of potent new stem cells that can robustly repair muscle damage, Blau said. "Aging is a stochastic but cumulative process," Cosgrove said. The word stochastic mean a process involving chance or probability. Cosgorce added that the team has shown that muscle stem cells progressively lose their stem cell function during aging. This treatment does not turn the clock back on dysfunctional stem cells in the aged population, he said. Rather, it stimulates stem cells from old muscle tissues that are still functional to begin dividing and self-renew."

The researchers found that, when transplanted back into the animal, the treated stem cells migrate to their natural niches and provide a long-lasting stem cell reserve to contribute to repeated demands for muscle repair. "In mice, we can take cells from an old animal, treat them for seven days during which time their numbers expand dramatically, as much as 60-fold and then return them to injured muscles in old animals to facilitate their repair," Blau said. In 2010, Blau's laboratory published a study in Science showing that muscle stem cells grown on soft hydrogel maintain their "stemness" in culture. In contrast, muscle stem cells grown on hard plastic tissue culture plates, the standard way to cultivate cells in the laboratory, quickly differentiate into more-specialized, but less therapeutically useful, muscle progenitor cells. The difference is likely due to the fact that soft hydrogel is more similar than rigid plastic to the muscle tissue environment in which the stem cells are naturally found. In the current study, the researchers found that targeting the p38 MAP kinase to induce the rapid expansion of the remaining functional stem cells from old mice required the soft hydrogel substrate. "The drug plus hydrogel boosts the small clones so that they undergo a burst of self-renewing divisions," Gilbert said. Thus, rejuvenation of the population is contingent on the synergy between biophysical and biochemical cues.

Finally, the researchers tested the ability of the rejuvenated old muscle stem cell population to repair muscle injury and restore strength in 2-year-old recipient mice. They teamed up with co-author Scott Delp, PhD, the James H. Clark Professor in the School of Engineering, who has designed a novel way to measure muscle strength in animals that had muscle injuries and then underwent the stem cell therapy. "We were able to show that transplantation of the old treated muscle stem cell population repaired the damage and restored strength to injured muscles of old mice," Cosgrove said. "Two months after transplantation, these muscles exhibited forces equivalent to young, uninjured muscles. This was the most encouraging finding of all." The researchers plan to continue their research to learn whether this technique could be used in humans. "If we could isolate the stem cells from an elderly person, expose them in culture to the proper conditions to rejuvenate them and transfer them back into a site of muscle injury, we may be able to use the person's own cells to aid recovery from trauma or to prevent localized muscle atrophy and weakness due to broken bones," Blau said. "This really opens a whole new avenue to enhance the repair of specific muscles in the elderly, especially after an injury. Our data pave the way for such a stem cell therapy."

### Other Stanford authors of the study include postdoctoral scholar Ermelinda Porpiglia, PhD; instructor Foteini Mourkioti, PhD; undergraduate student Steven Lee; senior research scientist Stephane Corbel, PhD; and medical resident Michael Llewellyn, MD, PhD. The research was supported by the National Institutes of Health (grants R25CA118681, K99AG042491, T32CA009151, K99AR061465, U01HL100397, U01HL099997, R01AG020961, R01HL096113 and R01AG009521), the California Institute for Regenerative Medicine and the Baxter Foundation.

See the original post:
Rejuvenated Stem Cells Help Aging Muscles Heal

Posted in Stem Cells | Comments Off on Rejuvenated Stem Cells Help Aging Muscles Heal

'Game changing' Japan stem-cell study questioned

Posted: February 18, 2014 at 11:45 am

TOKYO: A Japanese research institute on Tuesday said itwas probing its own study that promised a 'game changer' way to create stem cells, a feat hailed as revolutionary for the fast-developing field.

The findings, published by Japanese researcher Haruko Obokata and American partners in a January edition of the British journal Nature, outlined a simple and low-tech approach in the quest to grow transplant tissue in the lab.

The national institute Riken said Tuesday it had started an investigation over "questions" about the methodology and input data of the study, appointing several in-house and outside experts to pore over the revolutionary report. Obokata works for the institute.

At issue are allegations that the researchers used erroneous image data for the high-profile article, local media reported.

"The experts have already started hearings for the researchers involved in the articles," an institute spokesman said Tuesday, but declined to give further details.

For the moment, the institute is standing by the results -- a spokesman insisted the "findings themselves are unassailable."

Stem cells are primitive cells that, as they grow, differentiate into the various specialised cells that make up the different organs -- the brain, the heart, kidney and so on.

The goal is to create stem cells in the lab and nudge them to grow into these differentiated cells, thus replenishing organs damaged by disease or accident.

The researchers' groundbreaking findings said that white blood cells in newborn mice were returned to a versatile state by incubating them in a solution with high acidity for 25 minutes, followed by a five minute spin in a centrifuge and a seven-day spell of immersion in a growth culture.

Called stimulus-triggered acquisition of pluripotency (STAP) cells, the innovation breaks new ground.

See the original post:
'Game changing' Japan stem-cell study questioned

Posted in Stem Cells | Comments Off on 'Game changing' Japan stem-cell study questioned

BioTime CEO Dr. Michael West to Present at 9th Annual Stem Cell Summit

Posted: February 18, 2014 at 11:41 am

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that Chief Executive Officer Michael D. West, PhD will present at the 9th Annual Stem Cell Summit in New York. Dr. West will speak in the session Disrupting the Pharma Model with Allogeneic Stem Cell Therapies on February 18, 2014, starting at 9:05 a.m. EST.

Dr. West will discuss the potential comparative advantages of treating disease with BioTime's PureStem-based therapeutics compared to traditional small molecule pharmaceuticals and BioTime's product development strategy. The presentation will be made available on BioTime's website at http://www.biotimeinc.com.

About BioTime, Inc.

BioTime is a biotechnology company engaged in research and product development in the field of regenerative medicine. Regenerative medicine refers to therapies based on stem cell technology that are designed to rebuild cell and tissue function lost due to degenerative disease or injury. BioTimes focus is on pluripotent stem cell technology based on human embryonic stem (hES) cells and induced pluripotent stem (iPS) cells. hES and iPS cells provide a means of manufacturing every cell type in the human body and therefore show considerable promise for the development of a number of new therapeutic products. BioTimes therapeutic and research products include a wide array of proprietary PureStem progenitors, HyStem hydrogels, culture media, and differentiation kits. BioTime is developing Renevia (a HyStem product) as a biocompatible, implantable hyaluronan and collagen-based matrix for cell delivery in human clinical applications. In addition, BioTime has developed Hextend, a blood plasma volume expander for use in surgery, emergency trauma treatment and other applications. Hextend is manufactured and distributed in the U.S. by Hospira, Inc. and in South Korea by CJ CheilJedang Corporation under exclusive licensing agreements.

BioTime is also developing stem cell and other products for research, therapeutic, and diagnostic use through its subsidiaries:

Asterias Biotherapeutics, Inc. is a new subsidiary which has acquired the stem cell assets of Geron Corporation, including patents and other intellectual property, biological materials, reagents and equipment for the development of new therapeutic products for regenerative medicine.

OncoCyte Corporation is developing products and technologies to diagnose and treat cancer.

Cell Cure Neurosciences Ltd. (Cell Cure Neurosciences) is an Israel-based biotechnology company focused on developing stem cell-based therapies for retinal and neurological disorders, including the development of retinal pigment epithelial cells for the treatment of macular degeneration, and treatments for multiple sclerosis.

LifeMap Sciences, Inc. (LifeMap Sciences) markets, sells and distributes GeneCards, the leading human gene database, as part of an integrated database suite that also includes the LifeMap Discovery database of embryonic development, stem cell research and regenerative medicine, and MalaCards, the human disease database.

ES Cell International Pte Ltd., a Singapore private limited company, developed clinical and research grade hES cell lines and plans to market those cell lines and other BioTime research products in over-seas markets as part of BioTimes ESI BIO Division.

Link:
BioTime CEO Dr. Michael West to Present at 9th Annual Stem Cell Summit

Posted in Cell Medicine | Comments Off on BioTime CEO Dr. Michael West to Present at 9th Annual Stem Cell Summit

Cell-signaling pathway that plays key role in age-related muscle loss identified

Posted: February 18, 2014 at 11:41 am

Washington, Feb. 17 : A new study on why skeletal muscle stem cells stop dividing and renewing muscle mass during aging points up a unique therapeutic opportunity for managing muscle-wasting conditions in humans.

According to Bradley Olwin from University of Colorado Boulder, the loss of skeletal muscle mass and function as we age can lead to sarcopenia, a debilitating muscle-wasting condition that generally hits the elderly hardest.

The new study indicates that altering two particular cell-signaling pathways independently in aged mice enhances muscle stem cell renewal and improves muscle regeneration.

One cell-signaling pathway the team identified, known as p38 MAPK, appears to be a major player in making or breaking the skeletal muscle stem cell, or satellite cell, renewal process in adult mice, Olwin said.

Hyperactivation of the p38 MAPK cell-signaling pathway inhibits the renewal of muscle stem cells in aged mice, perhaps because of cellular stress and inflammatory responses acquired during the aging process.

"We showed that the level of signaling from this cellular pathway is very important to the renewal of the satellite cells in adult mice, which was a very big surprise," Olwin said.

The results could lead to the use of low-dose inhibitors, perhaps anti-inflammatory compounds, to calm the activity in the p38 MAPK cell-signaling pathway in human muscle stem cells, the researcher said.

The study was published in the journal Nature Medicine.

--ANI (Posted on 17-02-2014)

Follow this link:
Cell-signaling pathway that plays key role in age-related muscle loss identified

Posted in Cell Medicine | Comments Off on Cell-signaling pathway that plays key role in age-related muscle loss identified